Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Recurrent CMV Viremia Portends Poor Prognosis and Results in Significant Resource Utilization in Patients with Poor Graft Function Post Allogeneic Stem Cell Transplantation

Ashvind Anand Prabahran, Lynette C.Y. Chee, Rachel M Koldej, Michelle K Yong, David Ritchie

Blood (2021) 138 (Supplement 1): 4854.

https://doi.org/10.1182/blood-2021-153912

Published: 2021

Journal Articles

High Dose Valaciclovir As CMV Prophylaxis in Allogeneic Hematopoietic Stem Cell Recipients at High Risk of CMV Reactivation

Genevieve Douglas, B.App.Sc MBBS FRACP FRCPA, Michelle K Yong, MBBS, FRACP, MPH, PhD, Shio Yen Tio, MBBS, FRACP, Maggie Chau, BPharm(Hons) MClinPharm MBusMgt BCOP, Joe Sasadeusz, MBBS FRACP PhD, Monica Slavin, MBBS FRACP, Mingdi Xie, BNurs GradDip, David Ritchie, MB ChB, PhD FRACP, FRCPA, Lynette C.Y. Chee, MBBS,PhDFRACP,FRCPA

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-141764

Published: 2020

Journal Articles

The Economic and Health Utilization Cost of Clinically Significant Cytomegalovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation

Michelle K Yong, MBBS, FRACP, MPH, PhD, Shio Yen Tio, MBBS, FRACP, Jake Valentine, BBioMedSc, Joe Sasadeusz, MBBS FRACP PhD, Lynette C.Y. Chee, Ashish Bajel, MBBS, FRACP, FRCPA, David Ritchie, MD PhD, Monica Slavin, MBBS FRACP

Blood (2019) 134 (Supplement_1): 3437.

https://doi.org/10.1182/blood-2019-128227

Published: 2019

Journal Articles

Impact of Pre-Engraftment Cytomegalovirus Viraemia in Allogeneic Haematopoetic Stem Cell Transplant Recipients

Joanne L C Tan, MBBS, Shio Yen Tio, MBBS, FRACP, Michelle K Yong, MBBS, FRACP, MPH, PhD, David Ritchie, MD PhD

Blood (2019) 134 (Supplement_1): 5656.

https://doi.org/10.1182/blood-2019-122368

Published: 2019

Journal Articles

The Frequency of Cytomegalovirus (CMV)-Specific CD8+ T Cells Distinguishes CMV Clinical Outcomes Following Hematopoietic Allogeneic Stem Cell Transplant: A Prospective Multicentre Cohort Study

Michelle K Yong, Monica Slavin, David S. Ritchie, MDPhD, Andrew Spencer, Paul U Cameron, Orla Morrissey, Allen Cheng, Assia Samri, Guislaine Carcelain, Brigitte Autran, Sharon R Lewin

Blood (2015) 126 (23): 4312.

https://doi.org/10.1182/blood.V126.23.4312.4312

Published: 2015

Journal Articles

The Safety, Pharmacokinetics and Pharmacodynamics of KW-2478, a Novel Hsp90 Antagonist, in Patients with B-Cell Malignancies: A First-in-Man, Phase I, Multicentre, Open-Label, Dose Escalation Study

J. D. Cavenagh, MD, MRCP, K. Yong, J. Byrne, J. Cavet, P. Johnson, G. Morgan, C. Williams, S. Akinaga, G. Francis, J. Kilborn

Blood (2008) 112 (11): 2777.

https://doi.org/10.1182/blood.V112.11.2777.2777

Published: 2008

Journal Articles

Differentiation-linked changes in tyrosine phosphorylation, functional activity, and gene expression downstream from the granulocyte- macrophage colony-stimulating factor receptor

PJ Roberts, A Khwaja, AK Lie, A Bybee, K Yong, NS Thomas, DC Linch

Blood (1994) 84 (4): 1064–1073.

https://doi.org/10.1182/blood.V84.4.1064.1064

Published: 1994

Journal Articles

Human macrophage colony-stimulating factor levels are elevated in pregnancy and in immune thrombocytopenia [see comments]

K Yong, N Salooja, RE Donahue, U Hegde, DC Linch

Blood (1992) 80 (11): 2897–2902.

https://doi.org/10.1182/blood.V80.11.2897.2897

Published: 1992

Journal Articles

Lack of effect of granulocyte-macrophage and granulocyte colony- stimulating factors on cultured human endothelial cells [see comments]

K Yong, H Cohen, A Khwaja, HM Jones, DC Linch

Blood (1991) 77 (8): 1675–1680.

https://doi.org/10.1182/blood.V77.8.1675.1675

Published: 1991

Journal Articles

Isoquinolinesulfonamide protein kinase inhibitors H7 and H8 enhance the effects of granulocyte-macrophage colony-stimulating factor (GM-CSE) on neutrophil function and inhibit GM-CSF receptor internalization

A Khwaja, PJ Roberts, HM Jones, K Yong, MS Jaswon, DC Linch

Blood (1990) 76 (5): 996–1003.

https://doi.org/10.1182/blood.V76.5.996.996

Published: 1990

NARROW

Recurrent CMV Viremia Portends Poor Prognosis and Results in Significant Resource Utilization in Patients with Poor Graft Function Post Allogeneic Stem Cell Transplantation

High Dose Valaciclovir As CMV Prophylaxis in Allogeneic Hematopoietic Stem Cell Recipients at High Risk of CMV Reactivation

The Economic and Health Utilization Cost of Clinically Significant Cytomegalovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation

Impact of Pre-Engraftment Cytomegalovirus Viraemia in Allogeneic Haematopoetic Stem Cell Transplant Recipients

The Frequency of Cytomegalovirus (CMV)-Specific CD8+ T Cells Distinguishes CMV Clinical Outcomes Following Hematopoietic Allogeneic Stem Cell Transplant: A Prospective Multicentre Cohort Study

The Safety, Pharmacokinetics and Pharmacodynamics of KW-2478, a Novel Hsp90 Antagonist, in Patients with B-Cell Malignancies: A First-in-Man, Phase I, Multicentre, Open-Label, Dose Escalation Study

Differentiation-linked changes in tyrosine phosphorylation, functional activity, and gene expression downstream from the granulocyte- macrophage colony-stimulating factor receptor

Human macrophage colony-stimulating factor levels are elevated in pregnancy and in immune thrombocytopenia [see comments]

Lack of effect of granulocyte-macrophage and granulocyte colony- stimulating factors on cultured human endothelial cells [see comments]

Isoquinolinesulfonamide protein kinase inhibitors H7 and H8 enhance the effects of granulocyte-macrophage colony-stimulating factor (GM-CSE) on neutrophil function and inhibit GM-CSF receptor internalization

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only